EWTX
Price
$44.18
Change
+$0.89 (+2.06%)
Updated
Aug 21 closing price
Capitalization
4.8B
74 days until earnings call
Intraday BUY SELL Signals
GERN
Price
$1.52
Change
-$0.03 (-1.94%)
Updated
Aug 21 closing price
Capitalization
976.56M
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EWTX vs GERN

EWTX vs GERN Comparison Chart in %
View a ticker or compare two or three
VS
EWTX vs. GERN commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Hold and GERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (EWTX: $44.18 vs. GERN: $1.52)
Brand notoriety: EWTX and GERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 92% vs. GERN: 34%
Market capitalization -- EWTX: $4.8B vs. GERN: $976.56M
EWTX [@Biotechnology] is valued at $4.8B. GERN’s [@Biotechnology] market capitalization is $976.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileGERN’s FA Score has 0 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • GERN’s FA Score: 0 green, 5 red.
According to our system of comparison, EWTX is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 2 TA indicator(s) are bullish while GERN’s TA Score has 5 bullish TA indicator(s).

  • EWTX’s TA Score: 2 bullish, 5 bearish.
  • GERN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GERN is a better buy in the short-term than EWTX.

Price Growth

EWTX (@Biotechnology) experienced а +0.02% price change this week, while GERN (@Biotechnology) price change was +3.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

EWTX is expected to report earnings on Nov 05, 2026.

GERN is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($4.8B) has a higher market cap than GERN($977M). EWTX YTD gains are higher at: 78.037 vs. GERN (15.152). GERN has higher annual earnings (EBITDA): -34.48M vs. EWTX (-197.26M). EWTX has more cash in the bank: 500M vs. GERN (312M). EWTX has less debt than GERN: EWTX (3.79M) vs GERN (122M). GERN has higher revenues than EWTX: GERN (196M) vs EWTX (0).
EWTXGERNEWTX / GERN
Capitalization4.8B977M491%
EBITDA-197.26M-34.48M572%
Gain YTD78.03715.152515%
P/E RatioN/AN/A-
Revenue0196M-
Total Cash500M312M160%
Total Debt3.79M122M3%
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EWTXGERN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 19 days ago
76%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 6 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signal:
Gain/Loss:
GERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBSC91.600.75
+0.83%
JPMorgan BetaBuilders US Sml Cp Eq ETF
MEM44.440.31
+0.71%
Matthews Emerging Markets Eq Actv ETF
BEEX28.240.20
+0.71%
BeeHive ETF
PVAL54.270.37
+0.69%
Putnam Focused Large Cap Value ETF
RPHS8.80N/A
N/A
Regents Park Hedged Market Strategy ETF

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with IMNM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
+2.06%
IMNM - EWTX
38%
Loosely correlated
+1.57%
IMTX - EWTX
37%
Loosely correlated
+4.44%
FDMT - EWTX
37%
Loosely correlated
-1.68%
SLDB - EWTX
36%
Loosely correlated
+2.20%
GERN - EWTX
35%
Loosely correlated
-1.94%
More

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
-1.94%
SER - GERN
66%
Loosely correlated
+8.30%
VCYT - GERN
44%
Loosely correlated
+1.24%
RYTM - GERN
40%
Loosely correlated
+0.99%
VIR - GERN
38%
Loosely correlated
+6.19%
CRBU - GERN
38%
Loosely correlated
+3.11%
More